UCBJF - Investors growing more bullish on SMID cap biotech stocks
2024-02-04 17:16:46 ET
More on Alnylam Pharmaceuticals, Fusion Pharmaceuticals, etc.
- Merus Stock: Rally Seems Overdone
- Alnylam's Huge Opportunity
- Merus: (Maybe) Building A Better Bispecific
- Regeneron eyes Wegovy combo to improve quality of weight loss
- Alnylam reports preliminary Q4 global net product revenues